NEGR1 Genetic Variants and Risk for Virological Failure With Genotypic Resistance in Botswana
Background: Access to antiretroviral therapy (ART) in sub-Saharan Africa has expanded due to a large number of national initiatives. Published findings from the Tshepo study previously demonstrated that NNRTI-assigned ART had no effect on the development of virological failure with genotypic resistance (VF/r) when evaluating persons randomized to receive nevirapine versus efavirenz-based ART. Here, we…